JSNM2017/JSNMT2017/AOCNMB2017/ASNMT2017
Oct 5 - Oct 7, 2017PACIFICO Yokohama
You can search for presentations in this event.
Search
JSNM2017/JSNMT2017/AOCNMB2017/ASNMT2017
Oct 5 - Oct 7, 2017PACIFICO Yokohama
You can search for presentations in this event.
SearchSearch Results(843)
[PL-01]Sustainable Future Development of Nuclear Medicine in the Asia and Oceania Region
Tomio Inoue(Depatment of Radiology, Yokohama City University)
[PL-02]Contribution of radiological technologists to the development of the radiological technology
Hiroshi Watanabe(Japan Organization of Occupational Health and Safety, Yokohama Rosai Hospital)
[SKL]MEETING THE CANCER CHALLENGE IN DEVELOPING COUNTRIES
Yukiya Amano(IAEA Director General)
[KL]Nuclear Medicine Global Network: Telehealth and Trials
David Yang(University of Texas Health Sciences Center, USA)
[AAAS-01]Human resource development for Nuclear Medicine Professionals in Asia and Oceania
Jun Hatazawa(JSNM & AOFNMB President, Osaka University)
[AAAS-02]Promotion of Asian Nuclear Medicine driven by Asian School of Nuclear Medicine
Gang Huang(Dean of ASNM, Shanghai University of Medicine and Health Sciences, China)
[AAAS-03]Perspectives of nuclear medicine training in Asia
Henry Bom(ARCCNM Chairman, Chonnam National University, Korea)
[AAAS-04]Nuclear Medicine in Asia-Oceania
Andrew Scott(WFNMB President, Austin Hospital, Australia)
[IAEA-01]IAEA Curricula for Nuclear Medicine Professionals in Asia and the Pacific an Internationally recognized training programmes to support continuing medical education
Diana Paez(Department of Nuclear Sciences and Applications, IAEA)
[IAEA-02]Survey of Radiopharmaceuticals
Andrew Scott(Austin Hospital, Australia)
[IAEA-03]IAEA curriculum for Nuclear Medicine Professionals
Jun Hatazawa(Department of Nuclear Medicine and Tracer Kinetics, Osaka University)
[IAEA-04]Conflict of interest in Nuclear Medicine
Seyed Rasoul Zakavi(Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Iran)
[IS-01]Strategies for the Future of Nuclear Medicine
Bennett Greenspan(SNMMI President, Augusta University, USA)
[IS-02]EANM Strategies for the Future of Nuclear Medicine
Kristoff Muylle(EANM President, University Hospital Brussels, Belgium)
[IS-03]Strategies for the Future Nuclear Medicine
Andrew Scott(WFNMB President, Austin Hospital, Australia)
[IS-04]Greater Effectiveness of High LET Electron Emitters for Theragnostic Applications
Suresh Srivastava(Brookhaven National Laboratory, USA)
[IS-05]Boron Neutron Capture Therapy: Integration of Nuclear Physics, Nuclear Technology, and Nuclear Medicine
Jun Hatazawa(JSNM & AOFNMB President, Osaka University)
[IS-06]Strategies for the future of nuclear medicine
Seigo Kinuya(Department of Nuclear Medicine, Kanazawa University)
[SS-01]Suggestion of problems in the domestic development and the solution to inner irradiation therapy
Takeshi Sasaki(Regional Medical Care Planning Divisivon, Labour and Welfare)
[SS-02]Advocacy for Targeted Radionuclide Therapy in Japan: How Grassroots Organizations can Influence Health Care Policy?
Kenichi Oi(Cancer Support Community Japan)
[SS-03]Radioisotope Therapy(RIT) Advocacy: Changing Cancer Care for pNET in Japan
Yoshiyuki Majima(NPO PanCAN Japan)
[SS-04]The regulation of unapproved drugs under the Radiation Hazards Prevention Act
Hirotaka Oku(Div. of Regulation for Radiation, Radiation Protection Dept., Nuclear Regulation Authority)
[SS-05]Development of targeted radionuclide therapy for clinical purpose
Noboru Oriuchi(Advanced Clinical Research Center, Fukushima Medical University)
[SS-06]JRIA’s role for the development of Radionuclide Therapy (for the future)
Nobutaka Nakamura(Japan Radioisotope Association)
[SS-07]Targeted Radioisotope Therapy using alpha-emitters - Future perspectives
Tatsuya Higashi(National Institute of Radiological Sciences)
[CJP-01]Clinical value of whole-body PET/CT in patients with active rheumatic diseases
Hiroyuki Yamashita(Department of Connective tissue disease, National Center for Global Health and Medicine)
[CJP-02]Potential usefulness of 18F-FDG PET/CT in patients with rheumatism of unknown origin
Li Xuena(The First Hospital of China Medical University, China)
[CJP-03]FDG-PET/CT for HIV associated disorders and tuberculosis
Kazuo Kubota(Department Radiology, Southern TOHOKU General Hospital)
[CJP-04]PET-CT is a useful tool in the investigation of UFO: opinion from an infectious disease physician
Zhang Jingping(The First Hospital of China Medical University, China)
[CJP-05]Interesting FDG PET/CT imaging of IUO from Changhai Hospital
Cheng Chao(Shanghai Changhai Hospital, China)
[CJP-06]Multicenter study data analysis of FDG PET-CT in IUO differential diagnosis
Wang Qian(Peking University People's Hospital, China)
[JCS-01]The utility of SPECT imaging in the clinical diagnosis of Parkinson's disease and related disorders
Jumpei Suyama(Faculty of Health Sciences, Shonan University of Health Sciences)
[JCS-02]Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Fluorodeoxyglucose PET Images
Zhang Chenpeng(Shanghai Jiaotong University Renji Hospital)
[JCS-03]Importance of technical support for nuclear cardiology
Takayuki Shibutani(Department of Quantum Medical Technology, Kanazawa University)
[JCS-04]Routine Quality Control in Nuclear Department
Niu Pei(Jiaotong University Xinhua Hospital)
[JCS-05]Efforts of nurses in PET examination
Yuko Yakishiji(Kindai University Hospital)
[JCS-06]Importance of Examination Guidance Before PET Study
Xu Bin(Beijing Hospital)
[JCS-07]Biodistribution and PET imaging study of 64Cu-anti-CTLA4 mAb in melanoma bearing mice
Cuiping Jiang1,2、Lin Xie 1、Masayuki Hanyu1、Yiding Zhang1、Rikako Azuma1、Hisashi Suzuki1、Takashi Shimokawa3、Hidekatsu Wakizaka1、Shiming Zang2、Feng Wang2、Ming-Rong Zhang1(1.Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences、 2.Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University、3. Department of Basic Medical Sciences for Radiation Damages, NIRS, QST)
[JCS-08]Synthesis and characterization of SPECT/MRI dual-modality imaging agent SPION-PEG-FA-99mTc
Shen Yiming(Department of Nuclear Medicine, Tianjin Medical University General Hospital)
[PLJS-01]宇宙で活動するための技術 ～2040年火星探査の旅～
Seiya Ueno(Department of Systems Design for Ocean-Space, Yokohama National University)
[PLJS-02]“放射線”の使い方 ～病院編～
Madoka Sugiura(Department of Radiology, Yokohama City University Hospital)
[PLJS-03]画像検査でアレコレ見てみよう！
Matsuyoshi Ogawa(Yokohama City University Hospital)
[LS1-1-01]アミロイドイメージングの有用性
加藤 隆司(国立長寿医療研究センター 放射線診療部 核医学診療科)
[LS1-1-02]DLB診断に向けた脳血流SPECTによるCingulate Island Sign評価
今林 悦子(国立精神・神経医療研究センター 脳病態統合イメージングセンター臨床脳画像研究部)
[LS1-2-01]Q.Clearの原理と最新情報
三輪 健太(国際医療福祉大学 保健医療学部 放射線・情報科学科)
[LS1-2-02]全身用CZT SPECT/CT装置がもたらす核医学検査の新たなる展開
松成 一朗(埼玉医科大学病院 放射線科（核医学診療科）)
[LS1-3]“TAT －Targeted alpha therapy－”－アルファ線核種を用いたRI内用療法の可能性について－
東 達也(放射線医学総合研究所 臨床研究クラスタ分子イメージング診療治療研究部)
[LS1-4]ゾーフィゴⓇ 静注 放射線安全管理と運用のポイント
坂口 健太1、尾川 松義2(1.近畿大学医学部附属病院 中央放射線部、2.横浜市立大学附属病院 放射線部)
[LS1-5]Precision Medicine enabled by digital PET technology
Piotr Maniawski(Philips Healthcare)
843 results ( 1 - 50 )
- 1
- ...